Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

  1. Stolz, D.
  2. Hermansson, E.
  3. Ouwens, M.
  4. Singh, B.
  5. Sharma, A.
  6. Jackson, D.
  7. Darken, P.
  8. Marshall, J.
  9. Bowen, K.
  10. Müllerová, H.
  11. Alcázar Navarrete, B.
  12. Russell, R.
  13. Han, M.K.
  14. Tansey-Dwyer, D.
Aldizkaria:
Current Medical Research and Opinion

ISSN: 1473-4877,  0300-7995

Argitalpen urtea: 2023

Alea: 39

Zenbakia: 10

Orrialdeak: 1395-1405

Mota: Artikulua

DOI: 10.1080/03007995.2023.2247969 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus